Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg.
DailyMirror.news,Mumbai,14th August 2024: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food &